Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Genes (Basel) ; 11(5)2020 05 20.
Artículo en Inglés | MEDLINE | ID: mdl-32443852

RESUMEN

The prevalence of hypertension among African Americans (AAs) in the US is among the highest of any demographic and affects over two-thirds of AA women. Previous data from our laboratory suggest substantial differential gene expression (DGE) of mRNAs and microRNAs (miRNAs) exists within peripheral blood mononuclear cells (PBMCs) isolated from AA and white women with or without hypertension. We hypothesized that DGE by race may contribute to racial differences in hypertension. In a reanalysis of our previous dataset, we found that the Wiskott-Aldrich syndrome protein Verprolin-homologous protein 2 (WASF2 (also known as WAVE2)) is differentially expressed in AA women with hypertension, along with several other members of the actin cytoskeleton signaling pathway that plays a role in cell shape and branching of actin filaments. We performed an in silico miRNA target prediction analysis that suggested miRNA miR-1253 regulates WASF2. Transfection of miR-1253 mimics into human umbilical vein endothelial cells (HUVECs) and human aortic endothelial cells (HAECs) significantly repressed WASF2 mRNA and protein levels (p < 0.05), and a luciferase reporter assay confirmed that miR-1253 regulates the WASF2 3' UTR (p < 0.01). miR-1253 overexpression in HUVECs significantly increased HUVEC lamellipodia formation (p < 0.01), suggesting the miR-1253-WASF2 interaction may play a role in cell shape and actin cytoskeleton function. Together, we have identified novel roles for miR-1253 and WASF2 in a hypertension-related disparities context. This may ultimately lead to the discovery of additional actin-related genes which are important in the vascular-related complications of hypertension and influence the disproportionate susceptibility to hypertension among AAs in general and AA women in particular.


Asunto(s)
Hipertensión/genética , Racismo , Familia de Proteínas del Síndrome de Wiskott-Aldrich/genética , Síndrome de Wiskott-Aldrich/genética , Citoesqueleto de Actina/genética , Negro o Afroamericano/genética , Femenino , Regulación de la Expresión Génica/genética , Células Endoteliales de la Vena Umbilical Humana , Humanos , Hipertensión/epidemiología , Hipertensión/patología , Hipertensión/psicología , Leucocitos Mononucleares/metabolismo , Leucocitos Mononucleares/patología , Masculino , MicroARNs/genética , ARN Mensajero/genética , Población Blanca/genética , Síndrome de Wiskott-Aldrich/epidemiología , Síndrome de Wiskott-Aldrich/patología , Síndrome de Wiskott-Aldrich/psicología
2.
J Clin Immunol ; 39(8): 786-794, 2019 11.
Artículo en Inglés | MEDLINE | ID: mdl-31620947

RESUMEN

BACKGROUND: We undertook a study to determine the impact of Wiskott Aldrich Syndrome (WAS) and X-linked thrombocytopenia (XLT) and their therapies upon the health-related quality of life (HRQOL) of patients and their families. MATERIALS AND METHODS: We undertook a survey of patients and their families, who self-identified as having either WAS or XLT. We assessed the PedsQL™ 4.0, the parent proxy form, and the family impact module. These results were compared with normative data from previously published reports. RESULTS: Sixty-eight patients (29 patients completed both the PedsQL™ 4.0 and the parent proxy form; 21 completed only the PedsQL™ 4.0; and 18 completed only the parent proxy form) were included. In contrast to patient-reported outcomes, parents of patients who had a bone marrow transplant (BMT) reported that their children had better QOL scores compared with those who did not (82.6 vs. 73.3, p = 0.023). The QOL of patients vs. previously published normative data showed decreases in patient scores for psychosocial health (72.62 vs. 86.58, p = < 0.001), emotional functioning (69.91 vs. 82.64, p = < 0.001), social functioning (77.55 vs. 91.56, p = < 0.001), and school functioning (70.46 vs. 85.67, p = < 0.001). The family impact study revealed deficits in emotional, social, and cognitive functioning, communication, and worry. CONCLUSION: These results show that patients with WAS/XLT are significantly impacted with respect to QOL. BMT offered a better QOL for patients according to parents, but not as reported by the patients. Future studies should incorporate QOL to provide more data and a better understanding of outcomes for long-term survivors and decision-making regarding BMT.


Asunto(s)
Enfermedades Genéticas Ligadas al Cromosoma X/psicología , Padres/psicología , Medición de Resultados Informados por el Paciente , Calidad de Vida , Trombocitopenia/psicología , Síndrome de Wiskott-Aldrich/psicología , Adolescente , Trasplante de Médula Ósea , Cuidadores/psicología , Niño , Preescolar , Toma de Decisiones , Enfermedades Genéticas Ligadas al Cromosoma X/complicaciones , Enfermedades Genéticas Ligadas al Cromosoma X/inmunología , Enfermedades Genéticas Ligadas al Cromosoma X/terapia , Humanos , Masculino , Encuestas y Cuestionarios/estadística & datos numéricos , Sobrevivientes/psicología , Trombocitopenia/complicaciones , Trombocitopenia/inmunología , Trombocitopenia/terapia , Síndrome de Wiskott-Aldrich/complicaciones , Síndrome de Wiskott-Aldrich/inmunología , Síndrome de Wiskott-Aldrich/terapia , Adulto Joven
3.
Palliat Support Care ; 16(3): 367-370, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29380715

RESUMEN

ABSTRACTObjective:Pediatric bone marrow transplants represent a medically stressful, potentially traumatic experience for children and caregivers, and psychological support for parental caregivers is paramount to their long-term well-being. However, many medical centers do not have protocols in place to sustain caregiver well-being during these distressing experiences. METHOD: We report on a case of a 10-month-old infant with Wiskott Aldrich Syndrome who was hospitalized for bone marrow transplantation. RESULT: We describe the significant burden that fell upon caregivers during and after a bone marrow transplantation. SIGNIFICANCE OF RESULTS: This case helped guide our suggestions to improve care for caregivers. Several logistical hurdles could be overcome to alleviate some of these burdens. We suggest that a child psychologist or psychiatrist should be on patient care teams and be attentive to parental stress, impairments, or impediments to self-care, and signs of emergency of mental illness in this setting of medical trauma. Additionally, promotion of sleep hygiene and linkage to support systems can maximize resiliency. Finally, we believe that hospital administrators should partner with clinicians to facilitate routine support during highly stressful transitions of care.


Asunto(s)
Cuidadores/psicología , Síndrome de Wiskott-Aldrich/complicaciones , Trasplante de Médula Ósea/métodos , Costo de Enfermedad , Familia/psicología , Humanos , Lactante , Masculino , Pediatría/métodos , Sistemas de Apoyo Psicosocial , Encuestas y Cuestionarios , Síndrome de Wiskott-Aldrich/psicología
5.
DNA Cell Biol ; 12(7): 645-9, 1993 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-8397823

RESUMEN

The Wiskott-Aldrich syndrome (WAS) is a severe X-linked, recessive disorder, with a high mortality rate at early age due to hemorrhages, infections, and lymphoid malignancies. The molecular pathogenesis of the disease is unknown. Carrier females of WAS are clinically and immunologically normal, thus precluding carrier detection by simple laboratory tests. Major advances in molecular genetics have allowed mapping of the WAS gene to the pericentromeric short arm of the X chromosome, and have made carrier detection and prenatal diagnosis feasible by segregation analysis with closely linked polymorphic DNA markers. Furthermore, the observation that carriers of WAS exhibit a unilateral inactivation of the X chromosome in hematopoietic cells has provided a new tool for carrier detection. However, critical interpretation of molecular analysis data is essential to provide accurate genetic counseling to WAS families.


Asunto(s)
Tamización de Portadores Genéticos , Asesoramiento Genético , Síndrome de Wiskott-Aldrich/genética , Cromosoma X , Compensación de Dosificación (Genética) , Femenino , Ligamiento Genético , Marcadores Genéticos , Pruebas Genéticas , Humanos , Linaje , Síndrome de Wiskott-Aldrich/psicología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA